• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IPD

IMPEDIMED LIMITED - Corporate Spotlight

3.23% ! 3.0¢
Market Cap $60.82M  !

ImpediMed Limited is an Australia-based medical technology company. The Company uses... ImpediMed Limited is an Australia-based medical technology company. The Company uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The Company designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. SOZO uses its BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
3.0¢
Change
-0.001(3.23%)
Mkt cap ! $60.82M
Open High Low Value Volume
3.0¢ 3.0¢ 3.0¢ $6.432K 214.4K

Buyers (Bids)

No. Vol. Price($)
5 91954 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.1¢ 270442 3
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
IPD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.